NO20004835L - Fuktighetsaktiverbart terapeutisk system - Google Patents
Fuktighetsaktiverbart terapeutisk systemInfo
- Publication number
- NO20004835L NO20004835L NO20004835A NO20004835A NO20004835L NO 20004835 L NO20004835 L NO 20004835L NO 20004835 A NO20004835 A NO 20004835A NO 20004835 A NO20004835 A NO 20004835A NO 20004835 L NO20004835 L NO 20004835L
- Authority
- NO
- Norway
- Prior art keywords
- skin
- mucous membrane
- active agent
- activating agent
- therapeutic system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Terapeutisk system for tidsmessig og regulerbar avgivelse av minst ett terapeutisk virkestoff til den humane eller animalske organismen ved hjelp av diffusjon gjennom hud eller slimhinne, hvor virkestoffet for fremstilling og lagring først foreligger i en første tilstandsform i hvilken det er kjemisk stabilt og ikke tilstrekkelig permeabelt overfor huden eller slimhinnen, mens det på applikasjonsstedet ved tilførsel av fuktighet blir omdannet til en andre tilstandsform i hvilken det er egnet for diffusjonen gjennom huden eller slimhinnen og blir tatt opp i organismen, er kjennetegnet ved at det i den første tilstandsform er til stede i systemet som farmasøytisk akseptabelt salt, som foreligger som dispergert faststoff, og som ved tilførsel av fuktighet og ved også et i systemet inneholdt aktiverende middel kjemisk blir omdannet til den andre tilstandsformen i form av en syre eller base, som sammenlignet med saltformen fremskynder og øket blir tatt opp av huden eller slimhinnen inn i organismen, hvor det aktiverende middelet er et i vandig oppløsning surt eller basisk reagerende faststoff eller en blanding av slike faststoff, som med hensyn på sin totalvekt har innlagret en vannandel på minst 5% i sin faststoffstruktur eller bundet dertil, og hvor virkestoffsaltet og det aktiverende middelet foreligger adskilt fra hverandre.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19814087A DE19814087A1 (de) | 1998-03-30 | 1998-03-30 | Feuchtigkeitsaktivierbares therapeutisches System |
| PCT/EP1999/001802 WO1999049853A1 (de) | 1998-03-30 | 1999-03-18 | Feuchtigkeitsaktivierbares therapeutisches system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004835L true NO20004835L (no) | 2000-09-26 |
| NO20004835D0 NO20004835D0 (no) | 2000-09-26 |
Family
ID=7862905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004835A NO20004835D0 (no) | 1998-03-30 | 2000-09-26 | Fuktighetsaktiverbart terapeutisk system |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7175853B1 (no) |
| EP (1) | EP1069892B1 (no) |
| JP (1) | JP4252212B2 (no) |
| KR (1) | KR100550886B1 (no) |
| AT (1) | ATE221774T1 (no) |
| AU (1) | AU3331299A (no) |
| CA (1) | CA2326662C (no) |
| DE (2) | DE19814087A1 (no) |
| DK (1) | DK1069892T3 (no) |
| ES (1) | ES2182507T3 (no) |
| NO (1) | NO20004835D0 (no) |
| PT (1) | PT1069892E (no) |
| WO (1) | WO1999049853A1 (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| DE10137162A1 (de) * | 2001-07-30 | 2003-02-20 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol |
| DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
| DE102007041734A1 (de) * | 2006-12-20 | 2008-06-26 | Tesa Ag | Repulpierbare Klebmassen |
| JP5537412B2 (ja) * | 2008-02-27 | 2014-07-02 | 久光製薬株式会社 | 貼付製剤 |
| ES2661767T3 (es) * | 2008-02-27 | 2018-04-03 | Hisamitsu Pharmaceutical Co., Inc. | Parche adhesivo para la piel y producto envasado |
| DE102008013701A1 (de) * | 2008-03-11 | 2009-09-17 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit stabilisierter Membran |
| ES2589008T3 (es) * | 2009-04-24 | 2016-11-08 | Hisamitsu Pharmaceutical Co., Inc. | Bolsa de envase que contiene parche adhesivo y método para almacenar parche adhesivo |
| US9238025B2 (en) * | 2009-05-21 | 2016-01-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation comprising a ropinirole derivative |
| DE102009022915A1 (de) * | 2009-05-27 | 2010-12-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit gesteuertem Wirkstofffluss |
| KR101737960B1 (ko) * | 2009-11-12 | 2017-05-19 | 니혼 유니버서티 | 외용 의약 조성물 |
| US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| WO2011076621A2 (de) * | 2009-12-22 | 2011-06-30 | Acino Ag | Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten |
| EP2523731B1 (en) | 2010-01-14 | 2018-10-24 | Novartis AG | Use of an adrenal hormone-modifying agent |
| JP5820469B2 (ja) | 2010-04-30 | 2015-11-24 | テイコク ファーマ ユーエスエー インコーポレーテッド | プロピニルアミノインダンの経皮組成物 |
| DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| EP2688561B1 (en) | 2011-03-24 | 2018-08-22 | Teikoku Pharma USA, Inc. | Transdermal compositions comprising an active agent layer and an active agent conversion layer |
| ES2657016T3 (es) * | 2011-05-31 | 2018-03-01 | Hisamitsu Pharmaceutical Co., Inc. | Parche cutáneo adhesivo que contiene ropinirol y producto envasado del mismo |
| EP2776020B1 (en) | 2011-11-09 | 2019-09-11 | Teikoku Seiyaku Co., Ltd. | Methods for the treatment of skin neoplasms |
| US9481777B2 (en) | 2012-03-30 | 2016-11-01 | The Procter & Gamble Company | Method of dewatering in a continuous high internal phase emulsion foam forming process |
| JP6050896B2 (ja) | 2012-11-02 | 2016-12-21 | テイコク ファーマ ユーエスエー インコーポレーテッド | プロピニルアミノインダン経皮組成物 |
| WO2015137872A1 (en) * | 2014-03-13 | 2015-09-17 | Innovator Skåne Ab | Tubular or sheet-shaped drug delivery system |
| WO2018126225A1 (en) | 2016-12-29 | 2018-07-05 | International Bioceutical Company, Llc | Modular transdermal delivery system and associated methods of manufacture and use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE71287T1 (de) * | 1986-06-13 | 1992-01-15 | Alza Corp | Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit. |
| US4837027A (en) * | 1987-11-09 | 1989-06-06 | Alza Corporation | Transdermal drug delivery device |
| US4781924A (en) * | 1987-11-09 | 1988-11-01 | Alza Corporation | Transdermal drug delivery device |
| AT392587B (de) | 1988-03-03 | 1991-04-25 | Sandoz Ag | Pharmazeutische zusammensetzung enthaltend phenylcarbamate |
| DE3905051A1 (de) | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i) |
| DE3905050A1 (de) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii) |
| DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
| JPH04124128A (ja) * | 1990-09-13 | 1992-04-24 | Lion Corp | 肛門部疾患治療用貼付剤 |
| US5989586A (en) | 1992-10-05 | 1999-11-23 | Cygnus, Inc. | Two-phase matrix for sustained release drug delivery device |
| GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
| US5807570A (en) * | 1995-09-29 | 1998-09-15 | Cygnus, Inc. | Transdermal administration of ropinirole and analogs thereof |
-
1998
- 1998-03-30 DE DE19814087A patent/DE19814087A1/de not_active Withdrawn
-
1999
- 1999-03-18 PT PT99914523T patent/PT1069892E/pt unknown
- 1999-03-18 DK DK99914523T patent/DK1069892T3/da active
- 1999-03-18 DE DE59902270T patent/DE59902270D1/de not_active Expired - Lifetime
- 1999-03-18 EP EP99914523A patent/EP1069892B1/de not_active Expired - Lifetime
- 1999-03-18 WO PCT/EP1999/001802 patent/WO1999049853A1/de not_active Ceased
- 1999-03-18 CA CA002326662A patent/CA2326662C/en not_active Expired - Lifetime
- 1999-03-18 KR KR1020007010629A patent/KR100550886B1/ko not_active Expired - Lifetime
- 1999-03-18 ES ES99914523T patent/ES2182507T3/es not_active Expired - Lifetime
- 1999-03-18 AT AT99914523T patent/ATE221774T1/de active
- 1999-03-18 US US09/647,289 patent/US7175853B1/en not_active Expired - Lifetime
- 1999-03-18 JP JP2000540819A patent/JP4252212B2/ja not_active Expired - Lifetime
- 1999-03-18 AU AU33312/99A patent/AU3331299A/en not_active Abandoned
-
2000
- 2000-09-26 NO NO20004835A patent/NO20004835D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE59902270D1 (de) | 2002-09-12 |
| AU3331299A (en) | 1999-10-18 |
| CA2326662C (en) | 2007-01-16 |
| JP2002509879A (ja) | 2002-04-02 |
| JP4252212B2 (ja) | 2009-04-08 |
| ATE221774T1 (de) | 2002-08-15 |
| EP1069892B1 (de) | 2002-08-07 |
| DK1069892T3 (da) | 2002-12-02 |
| PT1069892E (pt) | 2002-12-31 |
| WO1999049853A1 (de) | 1999-10-07 |
| EP1069892A1 (de) | 2001-01-24 |
| KR20010042173A (ko) | 2001-05-25 |
| NO20004835D0 (no) | 2000-09-26 |
| ES2182507T3 (es) | 2003-03-01 |
| US7175853B1 (en) | 2007-02-13 |
| CA2326662A1 (en) | 1999-10-07 |
| KR100550886B1 (ko) | 2006-02-10 |
| DE19814087A1 (de) | 1999-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1069892T3 (da) | Fugtighedsaktiverbart terapeutisk system | |
| IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
| ES2172239T3 (es) | Sistema osmotico de liberacion de farmacos. | |
| WO2002085447A8 (en) | Microprojection array having a beneficial agent containing coating | |
| DE69715049D1 (de) | Tranilast enthaltendes externum und verfahren zu dessen herstellung | |
| TR200003158T2 (tr) | Jelleşebilen farmasötik bileşimler | |
| TW201412342A (zh) | 應用微囊化亞硝酸鹽和酸化水凝膠的延時產生一氧化氮的系統和方法 | |
| DK0724885T3 (da) | Pernasal sammensætning og pernasalt præparat indeholdende dette | |
| CA2107709A1 (en) | Calcium Agent for Plants | |
| US4039664A (en) | Topical griseofulvin composition and method | |
| HUP0003840A2 (hu) | Szabályozott hatóanyagleadású gyógyászati készítmények | |
| BR0210994A (pt) | Compostos farmacêuticos e de diagnósticos contendo nanopartìculas úteis para tratamento de tecidos e células | |
| BR0013283A (pt) | Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo | |
| HUP9902032A2 (hu) | Peszticid készítmény | |
| KR960021054A (ko) | 위장질환 치료제용 쑥추출물 | |
| BR9912533A (pt) | Composição farmacêutica tendo sabor melhorado | |
| PORZIO et al. | EFFICACY OF A NEW TOPICAL GEL-SPRAY FORMULATION OF KETOPROFEN LYSINE SALT IN THE RAT: PERCUTANEOUS PERMEATIONIN VITROANDIN VIVOAND PHARMACOLOGICAL ACTIVITY | |
| US4476115A (en) | Analgesic composition and method of treating subdermal pain | |
| DK1019037T3 (da) | Lægemiddel indeholdende delta-aminolevulinsyre | |
| TR200000249T2 (tr) | Bir etki maddesinin deri üzerinden bir organizmaya geçirilmesi ve deri üzerine tatbik işlemine dair transdermal terapötik sistem (TTS) | |
| JPH11302145A (ja) | 日やけ止め化粧料 | |
| BR0015422B1 (pt) | formulações de droga de liberação prolongada. | |
| WO2005060939A3 (en) | Controlled-release pharmaceutical formulation | |
| EP1297838A4 (en) | PRALMORELIN-CONTAINED NOSE DROP PREPARATIONS | |
| RU2181584C1 (ru) | Стимулятор роста волос |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |